Atherosclerosis(动脉粥样硬化)
- Cat.No. 产品名称 Information
- GC52497 Lactosylceramide (porcine RBC) A sphingolipid
- GC52281 Losartan Azide A potential impurity in commercial preparations of losartan
- GC52193 Eptifibatide A potent GPIIb/IIIa antagonist
- GC49784 AZD 2716 An sPLA2 inhibitor
- GC49690 (3R,5R)-Rosuvastatin (calcium salt) A potential impurity found in bulk preparations of rosuvastatin
- GC49671 2,3-Oxidosqualene An intermediate in the biosynthesis of sterols
- GC49629 6β-hydroxy Prednisolone A metabolite of prednisolone
- GC49496 Homocitrulline-d3 An internal standard for the quantification of homocitrulline
- GC49486 Meglutol-d3 An internal standard for the quantification of meglutol
- GC49340 Pitavastatin lactone-d4 An internal standard for the quantification of pitavastatin lactone
- GC49107 Rosuvastatin lactone The lactone form of rosuvastatin
- GC48744 Gliclazide-d4 An internal standard for the quantification of gliclazide
- GC48283 α-Linolenic Acid-d14 An internal standard for the quantification of α-Linolenic acid
- GC48206 Trimethylamine-d9 N-oxide An internal standard for the quantification of trimethylamine N-oxide
- GC48060 Rosuvastatin-d6 (sodium salt) An internal standard for the quantification of rosuvastatin
- GC47397 Gemfibrozil-d6 An internal standard for the quantification of gemfibrozil
- GC47085 Cholesterol-d7 An internal standard for the quantification of cholesterol
-
GC46912
Beauveriolide III
Beauveriolide III 是小鼠巨噬细胞中脂滴形成的抑制剂。
- GC46528 25-hydroxy Cholesterol-d6 An internal standard for the quantification of 25-hydroxy cholesterol
- GC46496 1-Stearoyl-2-Arachidonoyl-d8-sn-glycero-3-PC An internal standard for the quantification of 1-stearoyl-2-arachidonoyl-sn-glycero-3-PC
- GC46243 24-dehydro Cholesterol-d6 An internal standard for the quantification of 24-dehydro cholesterol
- GC46241 7-keto Cholesterol-d7 An internal standard for the quantification of 7-keto cholesterol
- GC45469 Hexacosanoic Acid-d4
- GC45439 Docosahexaenoic Acid-d5 MaxSpec• Standard An internal standard for the quantification of DHA
- GC45357 5-Chlorouracil A chlorinated derivative of uracil
- GC45057 TIQ-A A PARP1 inhibitor
- GC44910 Sodium Hydrogen Sulfide (hydrate) A H2S donor
- GC44669 POV-PC A CD36 ligand found in oxidized LDL
- GC44633 Phosphatidylserines (bovine) A glycerophospholipid
- GC44616 PGPC An oxidized phospholipid
- GC44573 PAz-PC A major oxLDL form
- GC44518 Osteocalcin (1-49) (human) (trifluoroacetate salt) A bone peptide
- GC44180 Methylcarbamyl PAF C-16 A stable analog of PAF C-16
- GC44093 Lutein A carotenoid with diverse biological activities
-
GC44011
KOdiA-PC
A potent CD36 ligand
-
GC43997
KDdiA-PC
CD36 ligand found in oxidized LDL
- GC43803 HA-1077 (hydrochloride) A ROCK inhibitor
- GC43263 Cholesteryl Stearate A cholesterol ester
- GC43160 CAY10485 An ACAT-1 and -2 inhibitor with antioxidant activity
-
GC43136
Campestanol
A phytosterol
- GC42994 Butanoyl PAF A PAF agonist that is present in oxLDL
- GC42924 Beraprost (sodium salt) A stable, orally active analog of prostacyclin
- GC42890 Azelaoyl PAF A potent PPARγ agonist
- GC42635 9(S)-HODE cholesteryl ester Extracted from atherosclerotic lesions; can be used as a standard
- GC42634 9(R)-HODE cholesteryl ester Extracted from atherosclerotic lesions; can be used as a standard
-
GC42411
4-hydroxy Nonenal Alkyne
4-HNE modified for click chemistry
- GC41897 13(S)-HOTrE A 15-LO product derived from GLA
- GC41895 13(S)-HODE cholesteryl ester Extracted from atherosclerotic lesions; can be used as a standard
- GC41893 13(R)-HODE cholesteryl ester Extracted from atherosclerotic lesions; can be used as a standard
- GC41666 (±)9-HODE cholesteryl ester A racemic monohydroxy fatty acid cholesteryl ester